JPH11504338A - チロシンおよび重合アレルゲンの組成物 - Google Patents
チロシンおよび重合アレルゲンの組成物Info
- Publication number
- JPH11504338A JPH11504338A JP8532981A JP53298196A JPH11504338A JP H11504338 A JPH11504338 A JP H11504338A JP 8532981 A JP8532981 A JP 8532981A JP 53298196 A JP53298196 A JP 53298196A JP H11504338 A JPH11504338 A JP H11504338A
- Authority
- JP
- Japan
- Prior art keywords
- allergen
- tyrosine
- solution
- composition
- polymerized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013566 allergen Substances 0.000 title claims abstract description 40
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 title claims abstract description 21
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 title description 2
- 239000000243 solution Substances 0.000 claims abstract description 24
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims abstract description 23
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 5
- 239000011260 aqueous acid Substances 0.000 claims abstract description 4
- 239000007864 aqueous solution Substances 0.000 claims abstract description 4
- 230000000379 polymerizing effect Effects 0.000 claims abstract description 3
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 230000000172 allergic effect Effects 0.000 claims description 4
- 208000010668 atopic eczema Diseases 0.000 claims description 4
- 238000000586 desensitisation Methods 0.000 claims description 4
- 238000002560 therapeutic procedure Methods 0.000 claims description 4
- 241000238740 Dermatophagoides pteronyssinus Species 0.000 claims description 3
- 230000003472 neutralizing effect Effects 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 229960004441 tyrosine Drugs 0.000 description 15
- 238000006386 neutralization reaction Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000007975 buffered saline Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 244000036975 Ambrosia artemisiifolia Species 0.000 description 1
- 235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000238713 Dermatophagoides farinae Species 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000003484 annual ragweed Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000006263 bur ragweed Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 235000003488 common ragweed Nutrition 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 239000002919 insect venom Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 235000009736 ragweed Nutrition 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9508785.4 | 1995-04-29 | ||
| GBGB9508785.4A GB9508785D0 (en) | 1995-04-29 | 1995-04-29 | Novel compositions |
| PCT/EP1996/001733 WO1996034626A1 (en) | 1995-04-29 | 1996-04-25 | Composition of tyrosine and polymerised allergen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH11504338A true JPH11504338A (ja) | 1999-04-20 |
Family
ID=10773769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8532981A Pending JPH11504338A (ja) | 1995-04-29 | 1996-04-25 | チロシンおよび重合アレルゲンの組成物 |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0825874A1 (pl) |
| JP (1) | JPH11504338A (pl) |
| KR (1) | KR19990008120A (pl) |
| CN (1) | CN1132629C (pl) |
| AU (1) | AU705873B2 (pl) |
| BG (1) | BG63990B1 (pl) |
| BR (1) | BR9608123A (pl) |
| CA (1) | CA2217388A1 (pl) |
| CZ (1) | CZ288401B6 (pl) |
| EA (1) | EA199700271A1 (pl) |
| GB (1) | GB9508785D0 (pl) |
| HU (1) | HUP9802237A3 (pl) |
| NO (1) | NO974893L (pl) |
| NZ (1) | NZ308080A (pl) |
| PL (1) | PL183484B1 (pl) |
| SK (1) | SK281877B6 (pl) |
| TR (1) | TR199701265T1 (pl) |
| WO (1) | WO1996034626A1 (pl) |
| ZA (1) | ZA963340B (pl) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014517824A (ja) * | 2011-04-21 | 2014-07-24 | アレジー セラピューティクス （ユーケー） リミテッド | ワクチン組成物を調製するプロセス |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9706957D0 (en) * | 1997-04-05 | 1997-05-21 | Smithkline Beecham Plc | Formulation |
| GB9820525D0 (en) | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
| GB0000891D0 (en) | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1377074A (en) * | 1971-07-13 | 1974-12-11 | Beecham Group Ltd | Process for preparing injectable compositions |
| US4070455A (en) * | 1974-02-16 | 1978-01-24 | Beecham Group Limited | Process for preparing injectable desensitizing compositions and products thereof in microparticle form |
| EP0058021A3 (en) * | 1981-02-06 | 1982-10-27 | Beecham Group Plc | Pharmaceutical compositions |
| ES2013359A6 (es) * | 1988-11-04 | 1990-05-01 | Corporacion Biolog Farmaceutic | Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados. |
-
1995
- 1995-04-29 GB GBGB9508785.4A patent/GB9508785D0/en active Pending
-
1996
- 1996-04-25 NZ NZ308080A patent/NZ308080A/xx not_active IP Right Cessation
- 1996-04-25 CA CA002217388A patent/CA2217388A1/en not_active Abandoned
- 1996-04-25 AU AU57616/96A patent/AU705873B2/en not_active Expired
- 1996-04-25 BR BR9608123A patent/BR9608123A/pt not_active Application Discontinuation
- 1996-04-25 PL PL96323104A patent/PL183484B1/pl unknown
- 1996-04-25 WO PCT/EP1996/001733 patent/WO1996034626A1/en not_active Ceased
- 1996-04-25 SK SK1461-97A patent/SK281877B6/sk not_active IP Right Cessation
- 1996-04-25 KR KR1019970707645A patent/KR19990008120A/ko not_active Ceased
- 1996-04-25 CZ CZ19973429A patent/CZ288401B6/cs not_active IP Right Cessation
- 1996-04-25 EP EP96914124A patent/EP0825874A1/en not_active Withdrawn
- 1996-04-25 CN CN96193592A patent/CN1132629C/zh not_active Expired - Lifetime
- 1996-04-25 EA EA199700271A patent/EA199700271A1/ru unknown
- 1996-04-25 JP JP8532981A patent/JPH11504338A/ja active Pending
- 1996-04-25 TR TR97/01265T patent/TR199701265T1/xx unknown
- 1996-04-25 HU HU9802237A patent/HUP9802237A3/hu unknown
- 1996-04-26 ZA ZA963340A patent/ZA963340B/xx unknown
-
1997
- 1997-10-23 NO NO974893A patent/NO974893L/no not_active Application Discontinuation
- 1997-10-29 BG BG102004A patent/BG63990B1/bg unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014517824A (ja) * | 2011-04-21 | 2014-07-24 | アレジー セラピューティクス （ユーケー） リミテッド | ワクチン組成物を調製するプロセス |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9508785D0 (en) | 1995-06-21 |
| NO974893D0 (no) | 1997-10-23 |
| BG102004A (en) | 1998-11-30 |
| ZA963340B (en) | 1997-03-27 |
| EA199700271A1 (ru) | 1998-04-30 |
| EP0825874A1 (en) | 1998-03-04 |
| AU5761696A (en) | 1996-11-21 |
| CN1132629C (zh) | 2003-12-31 |
| HK1010834A1 (en) | 1999-07-02 |
| SK146197A3 (en) | 1998-05-06 |
| HUP9802237A3 (en) | 2000-06-28 |
| PL183484B1 (pl) | 2002-06-28 |
| CA2217388A1 (en) | 1996-11-07 |
| KR19990008120A (ko) | 1999-01-25 |
| CN1183046A (zh) | 1998-05-27 |
| WO1996034626A1 (en) | 1996-11-07 |
| AU705873B2 (en) | 1999-06-03 |
| SK281877B6 (sk) | 2001-08-06 |
| CZ342997A3 (cs) | 1998-03-18 |
| TR199701265T1 (xx) | 1998-02-21 |
| HUP9802237A2 (hu) | 1999-02-01 |
| PL323104A1 (en) | 1998-03-16 |
| NO974893L (no) | 1997-10-23 |
| CZ288401B6 (en) | 2001-06-13 |
| BR9608123A (pt) | 1999-02-09 |
| BG63990B1 (bg) | 2003-09-30 |
| NZ308080A (en) | 1999-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0018561B1 (de) | Verfahren zur Stabilisierung von Blutgerinnungsfaktoren | |
| US4215200A (en) | Chemically and enzymatically modified collagen hemostatic agent | |
| US5663324A (en) | Method for producing underivatized, aqueous soluble β(1-3) glucan | |
| US4946450A (en) | Glucan/collagen therapeutic eye shields | |
| US4242501A (en) | Purification of pneumococcal capsular polysaccharides | |
| EP0157899B1 (en) | Multivalent pneumococcal vaccine and preparation thereof | |
| US4276283A (en) | Method of preparing an intravenously administrable immune globulin preparation containing antibodies and preparations produced according to this method | |
| US4271070A (en) | Chemically-modified fiber collagen hemostatic agents | |
| EP0490995A1 (en) | Method for producing soluble glucans | |
| EP0114351B1 (de) | Verfahren zur Herstellung eines Kollagen-Vlieses | |
| DE2404041A1 (de) | Blut-fraktionierungsverfahren | |
| US3469003A (en) | Injectable reconstituted collagen fluid adjuvant for vaccines and other drugs | |
| US20030206961A1 (en) | Starch | |
| US4070455A (en) | Process for preparing injectable desensitizing compositions and products thereof in microparticle form | |
| JP2003522255A (ja) | ニ官能ｌ−アミノ酸又はｌ−アミノエステル又はそれらの混合物と架橋したヒアルロン酸のゲル | |
| JPH11504338A (ja) | チロシンおよび重合アレルゲンの組成物 | |
| WO1996003147A1 (en) | Synthesis of chemical gels from polyelectrolyte polysaccharides by gamma-irradiation | |
| JPS5822444B2 (ja) | ヘンセイアレルゲンオユウスルチロシンノ セイゾウホウ | |
| HK1010834B (en) | Composition of tyrosine and polymerised allergen | |
| US20070142325A1 (en) | Starch | |
| CN117756958A (zh) | 一种制备肺炎链球菌荚膜多糖或其降解多糖的方法 | |
| MXPA97008336A (en) | Composition of tyrosine and allergen polymerize | |
| EP1325035B1 (en) | Pharmaceutically acceptable starch and manufacturing process thereof | |
| US3627642A (en) | Lysozyme salts | |
| JP2001519797A (ja) | アレルゲン処方 |